We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Hemogenyx Pharmaceuticals Plc | LSE:HEMO | London | Ordinary Share | GB00BYX3WZ24 | ORD GBP0.01 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.083 | -5.78% | 1.352 | 1.42 | 1.598 | 1.352 | 1.352 | 1.35 | 58,249 | 08:15:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Finance Services | 0 | -6.69M | -0.0050 | -2.86 | 19.26M |
Date | Subject | Author | Discuss |
---|---|---|---|
15/3/2024 16:00 | When can we expect your investment flyer on this Chairman?I can alert the necessary threads of an incoming useless ramp. | premium beeks | |
15/3/2024 14:30 | The Company intends to progress HEMO-CAR-T to phase 1 clinical trials commencing shortly. Could even be news on this as early as next week? | apotheki | |
15/3/2024 08:10 | countbasie115 Mar '24 - 08:06 - 999 of 999 (Filtered) | apotheki | |
14/3/2024 16:40 | certainly the cell therapy is evolving as pen-uni will not be waiting for Hemogenyx Cbr platform to limp out of the Petri-dish. | dreamtwister | |
14/3/2024 11:15 | Powder still dry, 1.3-1.5 incoming i think, that would be a great speculative buying area | jibba jabber | |
14/3/2024 09:57 | ApothekiWhat a hypocrite. You're on here everyday many times a day. Why do you only have the right to do this?What you shouldn't do is advise distressed investors to buy this under 2p ie 1.95 when you are not qualified to give advice to anyone about anything. | countbasie1 | |
14/3/2024 08:26 | the Usa v China security issues with communications has Bio-defense within its sights, this situation has been gathering pace ! i would trust hemogenyx to have a alternative supplier in the mist of the rising tensions......Tick.. | dreamtwister | |
13/3/2024 18:16 | Wow, 5 likes!Seems many others think you are a clunt as well. | premium beeks | |
13/3/2024 12:17 | Lol yeah I'm having that! | jibba jabber | |
13/3/2024 11:30 | Buy, buy, buy. | apotheki | |
13/3/2024 11:08 | Sell, sell, sell. | ken chung | |
13/3/2024 09:54 | 1.73/1.72 Extremely tight spread.This is ready to bounce back I'd say.A wee bit of news which cant be far away and up she goes | saint in exile | |
12/3/2024 19:00 | All Financial experts are here with various agenda`s, some realistic others just simply silly. Hemo is going nowhere quickly currently, Money being the only obstacle. Getting to trials costs millions, funding trials costs Multi Millions. Vlad is not able to utter a single word from here, UNTIL he gets that Funding. A PLACING ? Do not be ridiculous, there will be NO PLACING, the Money needed would send HEMO to the Wall. VLAD is currently in talks with a SUGAR DADDY to either fund the Trials for a piece of the action or even a straight cash deal to acquire Hemo & Vlad. Either, or, It will happen, just a matter of when. No other options are on the table, PHARMA is an extremely expensive Industry. The only other possibility is if this DISEASE X Surfaces and as Vlad has intimated Hemo have a NASAL spray that can be administered IMMEDIATELY, and Millions of Doses administered Very quickly. WHAT WOULD THAT BE WORTH.?? a new NCYT ? Where did that get to? Mega Bucks | steveberyl | |
12/3/2024 18:01 | I'd check back in 2-3 months time and that'll be something like. It's been to 1.3p with less shares in circulation before and it'll not be far off doing it again. | trying2trade | |
12/3/2024 16:20 | That’s easy it’s not the bottom. | albert35911 | |
12/3/2024 16:09 | yawns... once again a sloppy lack lustered interview with no substance ! | dreamtwister |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions